Skip to main content
. 2014 Jun 18;8(3):1051–1057. doi: 10.3892/ol.2014.2264

Figure 4.

Figure 4

Western blot analysis showing changes in Bcl-2 and BAX protein levels in dnATF5 U87 cells treated with HCMV. The expression of the Bcl-2 and BAX protein was not altered following HCMV infection between 0 and 48 h in dnATF5 U87 cells when compared with the control. dnATF5, dominant-negative activating transcription factor 5; Bcl-2, B-cell lymphoma/leukmia-2; BAX, Bcl-2-associated X protein; HMCV, human cytomegalovirus.